Rapid development of a new methodology is not altogether unusual in the current environment of diagnostic and interventional cardiology. Remarkable benefits might be projected, but scientists and clinicians alike must first develop an adequate understanding of the method's advantages and limitations . Myocardial contrast two-dimensional echocardiography represents a promising new diagnostic technique that has undergone extensive experimental validations as well as recent clinical trials . The preceding article in this issue of the Journal by Keller of al . (I) deals with an interesting application of contrast echocardiography and joins the growing literature in this field.
Progress in contrast echocardiography . After early exploration (2, 3) , the Journal of the American College of Cardiology published in 1984 a seminar (4) featuring articles on echo contrast agents, assessment of ischemic risk zones and study of regional myocardial blood flow and function, by myocardial contrast echocardiography . Despite encouraging progress, the need was recognized to develop contrast agents as quantitative microcirculatory tracers, standardize intracoronary or alternate injections and enhance the echo image quality that underlies valid tissue contrast analysis . Significant recent developments include sonicated or other agents containing extremely small microbubbles (3 to 5 yam) to he uniformly distributed and delivered in optimal concentrations (5, 6) . Computer-aided methods now permit dynamic study of myocardial contrast appearance-disappearance, yielding several potential indexes of perfusion (7) . In recognition of current limitations, efforts are under way to develop dedicated ultrasound instrumentation (8) . Contrast echocardiography is particularly well suited for detection and delin- 
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01988 by the American College orCardiology 935 cation of severely underperfused ml ocardium . for example . after coronary occlusion (9) . In the catheterization laboramry, when contrast echocardiography (with 2 ml intracoronary sonicated Renografin-76) was performed on patients with normal coronary arteries . anatomically corresponding myocardial regions were satisfactorily delineated (10) . This technique defines underperfused myocardiun . distal to all angiographicolly demonstrated severe coronary artery lesion and indicates a return of regional perfusion after successful vessel dilation by angioplasty (II) . Clinical contrast echocardiographic quantitation of myocardial blood flow remains to be demonstrated, but this ultimate goal seemed attainable in experiments with the use of new echo contrast agents and dynamic analysis (12) .
Is myocardial contrast echocardiography really necessary? The question might he asked whether this method provides significantly more information than that obtained through fully noninvasive two-dimensional eehocardiographic measerements of regional wall motion-The answer is that . although severe underperfusion is generally associated with severe dysfunction, there are exceptions and dissociation (for example, in early reperfusionl . The extent and configuration of underperfused myocardium may not be adequately defined by the area of dysfunction . With regard to the site and severity of vessel stenosis, myocardial blood flow clearly depends on the input from the epicardial coronary arteries, but other factors (for example, cardiac contraction) also have a major effect . The primary physiologic determinants of myocardial survival, that is, the level and distribution of tissue blood flow, may not be fully described by the severity of the coronary lesions . Therefore, myocardial perfusion measurements should supplement evaluation of coronary arteries and assessment of regional contractile function . In comparison with other promising techniques . contrast echocardiography combines real time tomographic imaging with good resolution. significant economy, flexibility of application and minimal toxicity.
Myocardial contrast echocardlographic characterization of coronary stenoses . Feinstein et al . (13) 12 patients with a wide range of single vessel stenosis, these investigators found a significant correlation between area under the echocardiographic intensitytime curve and percent coronary artery stenosis .
Evaluation of functional significance of coronary lesions . Because myocardial blood flow may not become impaired until a coronary artery is severely constricted, study of the functional significance of moderate coronary lesions is best accomplished by measuring the coronary reserve or potentiation of regional myocardial perfusion in the presence of pharmacologically induced hyperemia, for example, by irttracoronary papaverine . Cheiriff et al . (16) studied 40 patients, of whom 27 had various coronary lesions and 13 had normal coronary arteries . Contrast echocardiography was perforated before and 10 to 15 s after administration of 8 to 10 mg intracoronary papaverine . Peak regional myocardial echo intensities increased significantly after papaverine in the normal coronary subset, but remained unchanged in patients with angiographically demonstrated lesions .
Two advantages of the smaller (nine patients) study by Keller et a1 . (1) in this issue of the Journal are that it was limited to patients with single vesse! stenosis and it compared in each patient the 45 s posipapaverine effects in myocardial territories supplied by stenotic versus normal coronary arteries. Before papaverine, the stenotic and normal arteries yielded equivalent myocardial contrast enhancement. After papaverine, major enhancement was noted only distal to the normal vessel, and contrast echocardiography clearly defined a lower perfusion zone . In equivalent animal experiments, the peak myocardial contrast intensity index was highly variable and correlated poorly with myocardial blood flow measured by radioactive microspheres . This finding might be ascribed to factors related to contrast or ultrasound . Pre to early postpapaverine changes in area under the intensity-time curve correlated significantly with corresponding alterations in regional myocardial blood flow . For obvious reasons, similar validations could not be performed clinically. The authors (I) discussed mechanisms and methodologic issues, some of which still preclude absolute measurements of myocardial perfusion . Additional studies in larger patient subsets must also examine the more complex discrimination anticipated with multiple and perhaps less severe coronary artery stenoses . Although experimental and clinical reports (17 .18) reinforce the current perception of the safety and minimal toxicity of myocardial contrast echocardiography, wary vigilance regarding safety must continue, particularly when cardiac function is depressed . Future use ofbenign echo contrast agents with extremely small microbubbles, further standardization of injections and sophisticated imaging with ultrasound systems with expanded dynamic range should lead to significant further application of myocardial contrast echocardiography .
